These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35232849)

  • 1. Prevalence of COVID-19 in patients with rheumatoid arthritis (RA) already treated with hydroxychloroquine (HCQ) compared with HCQ-naive patients with RA: a multicentre cross-sectional study.
    Khoubnasabjafari M; Jouyban A; Malek Mahdavi A; Namvar L; Esalatmanesh K; Hajialilo M; Dastgiri S; Soroush M; Safiri S; Khabbazi A
    Postgrad Med J; 2022 Mar; 98(e2):e92-e93. PubMed ID: 35232849
    [No Abstract]   [Full Text] [Related]  

  • 2. COVID-19 Pneumonia during Hydroxychloroquine Treatment of Rheumatoid Arthritis.
    Gürsoy C; Tapan ÖO; Dogan E; Togan T; Demirbilek SG
    J Coll Physicians Surg Pak; 2020 Oct; 30(10):168-170. PubMed ID: 33291197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of hydroxychloroquine pre-exposure on infection with SARS-CoV-2 in rheumatic disease patients: a population-based cohort study.
    Jung SY; Kim MS; Kim MC; Choi SH; Chung JW; Choi ST
    Clin Microbiol Infect; 2021 Apr; 27(4):611-617. PubMed ID: 33316402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroxychloroquine and glycemia in women with rheumatoid arthritis and systemic lupus erythematosus.
    Penn SK; Kao AH; Schott LL; Elliott JR; Toledo FG; Kuller L; Manzi S; Wasko MC
    J Rheumatol; 2010 Jun; 37(6):1136-42. PubMed ID: 20436082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of hydroxychloroquine use with lipid profiles in rheumatoid arthritis: pharmacologic implications.
    Kerr G; Aujero M; Richards J; Sayles H; Davis L; Cannon G; Caplan L; Michaud K; Mikuls T
    Arthritis Care Res (Hoboken); 2014 Nov; 66(11):1619-26. PubMed ID: 24692402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and Structural Efficacy of Hydroxychloroquine in Rheumatoid Arthritis: A Systematic Review.
    Rempenault C; Combe B; Barnetche T; Gaujoux-Viala C; Lukas C; Morel J; Hua C
    Arthritis Care Res (Hoboken); 2020 Jan; 72(1):36-40. PubMed ID: 30629341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of depression, suicide and psychosis with hydroxychloroquine treatment for rheumatoid arthritis: a multinational network cohort study.
    Lane JCE; Weaver J; Kostka K; Duarte-Salles T; Abrahao MTF; Alghoul H; Alser O; Alshammari TM; Areia C; Biedermann P; Banda JM; Burn E; Casajust P; Fister K; Hardin J; Hester L; Hripcsak G; Kaas-Hansen BS; Khosla S; Kolovos S; Lynch KE; Makadia R; Mehta PP; Morales DR; Morgan-Stewart H; Mosseveld M; Newby D; Nyberg F; Ostropolets A; Woong Park R; Prats-Uribe A; Rao GA; Reich C; Rijnbeek P; Sena AG; Shoaibi A; Spotnitz M; Subbian V; Suchard MA; Vizcaya D; Wen H; Wilde M; Xie J; You SC; Zhang L; Lovestone S; Ryan P; Prieto-Alhambra D;
    Rheumatology (Oxford); 2021 Jul; 60(7):3222-3234. PubMed ID: 33367863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic and cardiovascular benefits of hydroxychloroquine in patients with rheumatoid arthritis: a systematic review and meta-analysis.
    Rempenault C; Combe B; Barnetche T; Gaujoux-Viala C; Lukas C; Morel J; Hua C
    Ann Rheum Dis; 2018 Jan; 77(1):98-103. PubMed ID: 28970215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-World Outcomes Associated With Methotrexate, Sulfasalazine, and Hydroxychloroquine Triple Therapy Versus Tumor Necrosis Factor Inhibitor/Methotrexate Combination Therapy in Patients With Rheumatoid Arthritis.
    Curtis JR; Palmer JL; Reed GW; Greenberg J; Pappas DA; Harrold LR; Kremer JM
    Arthritis Care Res (Hoboken); 2021 Aug; 73(8):1114-1124. PubMed ID: 32374918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroxychloroquine is neutral on incidental cataracts in patients with rheumatoid arthritis.
    Zhang Z; Ma X; Wang YH; Shi X; Wei JC
    Sci Rep; 2023 Apr; 13(1):5576. PubMed ID: 37019978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baseline use of hydroxychloroquine or immunosuppressive drugs and the risk of coronavirus disease 2019.
    Kim JW; Kwak SG; Lee H; Kim SK; Choe JY; Park SH
    Korean J Intern Med; 2022 May; 37(3):673-680. PubMed ID: 33706472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases.
    Rainsford KD; Parke AL; Clifford-Rashotte M; Kean WF
    Inflammopharmacology; 2015 Oct; 23(5):231-69. PubMed ID: 26246395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19.
    Singh B; Ryan H; Kredo T; Chaplin M; Fletcher T
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013587. PubMed ID: 33624299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxychloroquine concentration-response relationships in patients with rheumatoid arthritis.
    Munster T; Gibbs JP; Shen D; Baethge BA; Botstein GR; Caldwell J; Dietz F; Ettlinger R; Golden HE; Lindsley H; McLaughlin GE; Moreland LW; Roberts WN; Rooney TW; Rothschild B; Sack M; Sebba AI; Weisman M; Welch KE; Yocum D; Furst DE
    Arthritis Rheum; 2002 Jun; 46(6):1460-9. PubMed ID: 12115175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxychloroquine may be associated with reduced risk of coronary artery diseases in patients with rheumatoid arthritis: A nationwide population-based cohort study.
    Hung YM; Wang YH; Lin L; Wang PYP; Chiou JY; Wei JC
    Int J Clin Pract; 2018 May; 72(5):e13095. PubMed ID: 29691971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients with rheumatoid arthritis exposed to COVID-19: A family cluster report.
    Cai S; Sun W; Zhong J; Dong L
    Mod Rheumatol; 2021 Mar; 31(2):514-517. PubMed ID: 32930030
    [No Abstract]   [Full Text] [Related]  

  • 17. Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in early rheumatoid arthritis: 2-year quality-of-life results of the randomised, controlled, SWEFOT trial.
    Karlsson JA; Neovius M; Nilsson JÅ; Petersson IF; Bratt J; van Vollenhoven RF; Ernestam S; Geborek P
    Ann Rheum Dis; 2013 Dec; 72(12):1927-33. PubMed ID: 23196701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methotrexate, hydroxychloroquine, and intramuscular gold in rheumatoid arthritis: relative area under the curve effectiveness and sequence effects.
    Hurst S; Kallan MJ; Wolfe FJ; Fries JF; Albert DA
    J Rheumatol; 2002 Aug; 29(8):1639-45. PubMed ID: 12180722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of hydroxychloroquine on insulin sensitivity and lipid parameters in rheumatoid arthritis patients without diabetes mellitus: a randomized, blinded crossover trial.
    Solomon DH; Garg R; Lu B; Todd DJ; Mercer E; Norton T; Massarotti E
    Arthritis Care Res (Hoboken); 2014 Aug; 66(8):1246-51. PubMed ID: 24470436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of hydroxychloroquine sulphate in rheumatoid arthritis: a randomized, double-blind, placebo controlled clinical trial--an Indian experience.
    Das SK; Pareek A; Mathur DS; Wanchu A; Srivastava R; Agarwal GG; Chauhan RS
    Curr Med Res Opin; 2007 Sep; 23(9):2227-34. PubMed ID: 17692155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.